These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
570 related items for PubMed ID: 6202068
1. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R. Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
2. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct]. Rühle H. Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541 [No Abstract] [Full Text] [Related]
3. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics]. Schröder R. Dtsch Med Wochenschr; 1981 Apr 24; 106(17):546-53. PubMed ID: 6111439 [No Abstract] [Full Text] [Related]
4. [Correction of thrombophilia]. Caruzzo C, Marcolongo M, Arpino E, Di Summa M. Minerva Cardioangiol; 1981 Apr 24; 29(1-2):13-8. PubMed ID: 6112717 [No Abstract] [Full Text] [Related]
5. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey]. Spitzer W, Durst OE, Lang E. Fortschr Med; 1983 Jan 13; 101(1-2):22-30. PubMed ID: 6826125 [Abstract] [Full Text] [Related]
6. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction]. Offerhaus L. Ned Tijdschr Geneeskd; 1983 Apr 16; 127(16):673-9. PubMed ID: 6134240 [No Abstract] [Full Text] [Related]
7. [Comparative statistical study of the treatment of myocardial infarct with anticoagulants and anti-aggregants]. Melloni GF, Lureti GF, Minoja GM, Melloni CF, Scarlatti GF, Facchetti M, Fassini G. Boll Soc Ital Cardiol; 1977 Apr 16; 22(7):1017-26. PubMed ID: 87208 [No Abstract] [Full Text] [Related]
10. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease? Poliwoda H, Avenarius HJ. Int Angiol; 1986 Apr 08; 5(3):169-80. PubMed ID: 2435823 [Abstract] [Full Text] [Related]
11. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents]. Gross R. Chirurg; 1968 May 08; 39(5):201-8. PubMed ID: 4974339 [No Abstract] [Full Text] [Related]
12. The prevention of thrombosis. Bove LG. J Maine Med Assoc; 1974 Oct 08; 65(10):233-5. PubMed ID: 4610070 [No Abstract] [Full Text] [Related]
13. [Present situation of therapy with platelet aggregation inhibitors]. Poliwoda H. Acta Med Austriaca Suppl; 1982 Oct 08; 25():55-61. PubMed ID: 6958157 [No Abstract] [Full Text] [Related]
14. Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status. Wessler S, Sherman LA. Circulation; 1972 Apr 08; 45(4):911-8. PubMed ID: 4555190 [No Abstract] [Full Text] [Related]
15. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)]. Loew D, Breddin K, Uberla K. MMW Munch Med Wochenschr; 1982 Jan 08; 124(1):46-56. PubMed ID: 6120454 [No Abstract] [Full Text] [Related]
16. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions]. Ostendorf P. Internist (Berl); 1979 Nov 08; 20(11):539-46. PubMed ID: 396265 [No Abstract] [Full Text] [Related]
17. [Prevention and therapy with anticoagulants. Indications, experiences, results]. Bruhn HD. Intensivmed Prax; 1979 Nov 08; (2):91-7. PubMed ID: 553881 [No Abstract] [Full Text] [Related]
18. [Fibrinolytics. 46]. Wagler M. Pharm Prax; 1970 Nov 08; 6():141-2. PubMed ID: 4195438 [No Abstract] [Full Text] [Related]
19. [Prophylactic value of platelet anti-aggregants in coronary disease]. Verstraete M. Clin Ter; 1979 Oct 31; 91(2):117-27. PubMed ID: 396098 [No Abstract] [Full Text] [Related]
20. [Prevention of myocardial infarction by chemotherapy]. Toshima H, Adachi K. Nihon Rinsho; 1982 Oct 31; 40(11):2465-70. PubMed ID: 6130172 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]